Prestigious Annual Awards Program Celebrates a Decade of Recognizing the World’s Most Innovative Financial Technology Companies ...

Recognition Highlights Propel's Role in Expanding Credit Access for Underserved Consumers Through AI-Driven InnovationTORONTO, March 19, 2026 /CNW/ - ...

Is TTWO a good stock to buy? We came across a bullish thesis on Take-Two Interactive Software, Inc. on R. Dennis’s Substack ...

Is BCRX a good stock to buy? We came across a bullish thesis on BioCryst Pharmaceuticals, Inc. on TradersPro’s Substack. In ...

SUNNY ISLES BEACH, FL / ACCESS Newswire / March 19, 2026 / Elektros, Inc. (OTC:ELEK), an emerging innovator in the electric vehicle (EV) infrastructure and energy solutions sector, today announced the ...

Datalign Advisory, a comprehensive AI-native organic growth platform serving the wealth management industry, today announced it has been named “Financial Advisory Platform of the Year” in the 2026 ...

AtaiBeckley is a clinical-stage psychedelic biotech targeting TRD and SAD, with BPL-003 as its lead value driver. Learn more about ATAI stock here.

More than 5,000 shelved drug candidates were discontinued for business reasons, not safety ones. A new push aims to match them with the highest need.

Late-breaking AMETHYST Part A study results to be presented, showing safety and efficacy of litifilimab in cutaneous lupus erythematosus (CLE)Litifilimab was recently granted Breakthrough Therapy Desi ...

Breakthrough Therapy Designation granted to nomlabofusp for the treatment of adults and children with FA based on FDA’s review of available clinical data from open label studyContinued alignment with ...

At a Capital Markets Day in London, SIML will highlight how Syncona’s maturing clinical portfolio, strengthening sector fundamentals, and improving market conditions position it for near-term value ...

RiskHedge helps investors profit from disruption by providing research on the latest breakthrough technologies and the stocks driving th ...